Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Alirocumab (Praluent) for Treatment of Hyperlipidemia.
The Ino80 complex prevents invasion of euchromatin into silent chromatin.
The pediatric asthma yardstick: Practical recommendations for a sustained step-up in asthma therapy for children with inadequately controlled asthma.
See All 3 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Alirocumab (Praluent) for Treatment of Hyperlipidemia.
Turner PL, Barry KA. Alirocumab (Praluent) for Treatment of Hyperlipidemia. Am Fam Physician. 2016 Aug 15; 94(4):310-1.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Anticholesteremic Agents
Atherosclerosis
Confusion
Humans
Hyperlipidemias
Hyperlipoproteinemia Type II
Memory Disorders
authors with profiles
Kathleen Anne Barry MD